Breathing support for cystic fibrosis still has uncertain trial evidence
A review found very low certainty across measured outcomes, leaving questions about mucus clearance, lung function, sleep and acceptability unresolved.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
This review could not establish how much noninvasive positive pressure ventilation helps people with cystic fibrosis, either during a lung flare-up or when their condition is stable. Evidence across the reported outcomes was very uncertain. That does not establish that the treatment is ineffective; it limits what these trials can reliably tell us.
Most trials were small, lasted no longer than 3 months and missed outcomes the reviewers considered critical. This abstract-based account cannot assess the full trial methods or safety data.
What researchers found
Short-term sleep quality
Bilevel breathing support versus room air in people with stable cystic fibrosis; the review did not establish a clear benefit.
Different clinical situations
Trials examined different ventilation methods, comparison treatments and clinical situations. Those differences matter: a result during an acute flare-up does not automatically describe what happens with longer use in someone whose disease is stable.
Limited combined evidence
Most outcomes came from individual studies, so the reviewers could combine results for only a limited part of the evidence. Reports of less tiredness after bilevel support had too little data for a firm conclusion.
The original publication
Non-invasive ventilation for cystic fibrosis.
Sousa AS, Rocha-Filho CR, Rocha A et al.
Cochrane Database Syst Rev · 2025
- PubMed ID
- 41251249
- Record checked
Linked publication notices
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.